original ) (raw )Calcium channel blockers and hypertension
Allegra Battistoni
Journal of cardiovascular pharmacology and therapeutics, 2015
View PDFchevron_right
Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Jackson Wright
Hypertension, 2006
View PDFchevron_right
Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients
Niko Kaciroti
Journal of the American Heart Association, 2018
View PDFchevron_right
The role of calcium channel blockers in the treatment of hypertension
Luigi Cubeddu
American Heart Journal, 1986
View PDFchevron_right
Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a Diuretic
Mohammad Saklayen , Thomas Wiegmann
Archives of Internal Medicine, 2005
View PDFchevron_right
Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs. a Diuretic. A Report From the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Joshua Barzilay
Acc Current Journal Review, 2005
View PDFchevron_right
Combination Angiotensin Receptor Blocker/Hydrochlorothiazide as Initial Therapy in the Treatment of Patients With Severe Hypertension
Robin Mukherjee
The Journal of Clinical Hypertension, 2004
View PDFchevron_right
Effectiveness and safety assessment of beta-blockers, calcium channel blockers, and angiotensin receptor blockers in hypertensive patients: a prospective study
Dhruvi Pandit
American journal of cardiovascular disease, 2021
View PDFchevron_right
Efficacy and safety of ACT-280778, a dual L- and T-type calcium channel blocker, in patients with mild-to-moderate essential hypertension: results from a phase 2a, randomized, double-blind, placebo- and active-controlled trial (REDUCE–1)
Jasper Dingemanse
View PDFchevron_right
Effect of Antihypertensive Treatment on Cardiac and Subcutaneous Artery Structure A Comparison Between Calcium Channel Blocker and Thiazide-Based Regimens
Inger Sihm
American Journal of Hypertension, 1998
View PDFchevron_right
L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease
Yoshiyuki Toya
2013
View PDFchevron_right
Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension
Jasper Dingemanse
Journal of human hypertension, 2015
View PDFchevron_right
Current Treatment of Patients with Hypertension
Stefano Taddei
Drugs, 2003
View PDFchevron_right
The pharmacological basis for the combination of calcium channel antagonists and angiotensin converting enzyme inhibitors in the treatment of hypertension
Bernd Mühlbauer
Journal of Hypertension, 1995
View PDFchevron_right
Renal-Protective Effect of T- and L-Type Calcium Channel Blockers in Hypertensive Patients: An Amlodipine-to-Benidipine Changeover (ABC) Study
Tomohiro Katsuya
Hypertension Research, 2007
View PDFchevron_right
A Comparative Evaluation of Amlodipine and Hydrochlorothiazide as Monotherapy in the Treatment of Isolated Systolic Hypertension in the Elderly
mario olmos
Clinical Drug Investigation, 2000
View PDFchevron_right
Effects of Cilnidipine, an L/N-Type Calcium Channel Blocker, on Carotid Atherosclerosis in Japanese Post-Stroke Hypertensive Patients: Results from the CA-ATTEND Study
Hirofumi Maruyama
Journal of atherosclerosis and thrombosis, 2017
View PDFchevron_right
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Joe Blanton
2003
View PDFchevron_right
Antihypertensive Drug Therapies and the Risk of Ischemic Stroke
Curt Furberg
Archives of Internal Medicine, 2001
View PDFchevron_right
Angiotensin II Receptor Blocker-based Therapy in Japanese Elderly, High-risk, Hypertensive Patients
Hisao Ogawa
The American Journal of Medicine, 2012
View PDFchevron_right
Calcium Antagonists: Effects on Cardio-Renal Risk in Hypertensive Patients
Sandeep Nathan
Hypertension, 2005
View PDFchevron_right
Therapy in the elderly hypertensive
Peter Trenkwalder
Journal of the renin-angiotensin-aldosterone system : JRAAS, 2002
View PDFchevron_right
Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension
Anique Ducharme
Clinical Therapeutics, 2004
View PDFchevron_right
Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension
Joseph Diamond
American journal of hypertension, 2001
View PDFchevron_right
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT
Luis Miguel
Lancet, 2000
View PDFchevron_right
Calcium Channel Blockers in Secondary Cardiovascular Prevention and Risk of Acute Events: Real-World Evidence from Nested Case-Control Studies on Italian Hypertensive Elderly
A. Mugelli
Clinical drug investigation, 2017
View PDFchevron_right
Vascular Protection of Dual Therapy (Atorvastatin- Amlodipine) in Hypertensive Patients Combined Antihypertensive and Lipid- Lowering Therapies in the Clinical Practice
Maria Carmen Duran Ruiz
Journal of the American Society of Nephrology , 2007
View PDFchevron_right
A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease
José Cangiano
JAMA, 2003
View PDFchevron_right
Role of Diuretics in the Prevention of Heart Failure: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Curt Furberg
Circulation, 2006
View PDFchevron_right
Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension
Luc Poirier
American Journal of Hypertension, 1995
View PDFchevron_right
Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension
Michelle Baron
American journal of hypertension, 2004
View PDFchevron_right
Calcium antagonists: Not appropriate as first line antihypertensive agents
Curt Furberg
1996
View PDFchevron_right
Influence of ATII blockers and calcium channel blockers on renal vascular resistance in patients with essential hypertension
Kresimir Galesic
Collegium Antropologicum, 2009
View PDFchevron_right
A systematic review of the blood pressure lowering efficacy of thiazide and loop diuretics in the treatment of primary hypertension
Dr. Vijaya M Musini
View PDFchevron_right